Cancer Stem Cells Market Growth, Size, Trends and Competitive Analysis 2022-2032
Cancer Stem Cells Market Size- By Cancer, By Mode Of Action, By Transplantation, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032
| Published: Dec-2022 | Report ID: HLCA2220 | Pages: 1 - 226 | Formats*: |
| Category : Healthcare | |||
Global Cancer Stem Cells Market Overview:
According to SPER Market Research, the Global Cancer Stem Cells Market is estimated to reach USD 2.68 billion by 2032 with a CAGR of 10.29%.
The tumour’s other cell types are produced by the cancer cell, which has the capacity to divide and grow continuously. Cancer stem cells are believed to oversee tumour development, metastasis, and recurrence. These are the rare forms of godlike cells called cancer stem cells are found in tumours and give rise to a wide range of cell types that make up the tumour. These cells have been identified in several human tumours and may serve as targets for cancer therapy. Most anti-cancer medications function by inducing the death of cancer cells. Even though these treatments seem to be working, some individuals nonetheless have a disease recurrence. The primary driver fuelling the expansion of the cancer stem cell market is the rising incidence of cancer in the world.
Impact of COVID-19 on the Global Cancer Stem Cells Market
The cancer stem cell sector has prospered from the COVID-19 epidemic. The advent of genetic engineering, which modifies human DNA, and organoid technology, which creates the three-dimensional structure of the tissue from originating stem cells, are two of the most significant strides in stem cell research during COVID-19. The advent of genetic engineering, which modifies human DNA, and organoid technology, which creates the three-dimensional structure of the tissue from stem cells, have been two of the most important strides in stem cell research during Covid-19. This element had a favourable effect on the world market for cancer stem cells. Additionally, there has been an increase in the use of allogeneic stem cell therapy and hematopoietic cell transplantation (HCT), particularly among cancer patients who have Covid-19 infections.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Cancer, By Mode Of Action, By Transplantation, By Application, By End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Companies Covered | AbbVie Inc., Advanced Cell Diagnostics Inc., Bionomics, BioNTech, BioTime Inc., Caladrius Biosciences Inc., Celgene Corp., ExCellThera, Gamida Cell, Irvine Scientific, Lonza, MacroGenics, Inc., Menarini Group, Merck KGaA, Mereo BioPharma, Miltenyi, Biotec, PromoCell GmbH, Propanc Biopharma, Silicon Biosystems, Sino Biological Inc., Thermo Fisher Scientific Inc., ViaCyte Inc. |
Global Cancer Stem Cells Market Segmentation:
By Caner: Based on the Caner, Global Cancer Stem Cells Market is segmented as; Acute Leukemia, Aplastic Anemia, Chronic Lymphocytic Leukemia, Osteopetrosis.
By Mode Of Action: Based on the Mode Of Action, Global Cancer Stem Cells Market is segmented as; Targeted Cancerous Stem Cells {By Anti-CSC Therapeutics (Pathway Inhibitors, Surface Marker Based, Immuno-evasion and Targeting Tumour Microenvironment, Nanoparticle-based Therapies), Products (Cell-Culturing, Cell-Separation, Cell-Analysis, Molecular Analysis)}, Stem Cell Based Cancer Therapy (Autologous SC Transplant, Allogeneic SC Transplant).
By Transplantation: Based on the Transplantation, Global Cancer Stem Cells Market is segmented as; Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy.
By Application: Based on the Application, Global Cancer Stem Cells Market is segmented as; Blood Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer.
By Region: Due to improvements in healthcare infrastructure and strong reimbursement policies across the region, North America had the substantial share, accounting for more than two-fifths of the worldwide cancer stem cell market. On the other hand, the Asia-Pacific area will have the fastest growth in the following years. This is because the governments of China, Japan, and India are developing regulations for the development of stem cell research facilities and investing in healthcare infrastructure.
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data2.1.2 Primary data2.1.3 SPER’s internal database2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity, and Challenges analysis
4.1.1 Drivers4.1.2 Restraints4.1.3 Opportunities4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Cancer Stem Cells Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths5.1.2 Weaknesses5.1.3 Opportunities5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape5.2.2 Economic landscape5.2.3 Social landscape5.2.4 Technological landscape5.2.5 Environmental landscape5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers5.3.2 Bargaining power of Buyers5.3.3 Threat of Substitute5.3.4 Threat of new entrant5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Global Cancer Stem Cells Market, By Cancer, 2019-2032 (USD Million)
6.1. Acute Leukemia6.2. Aplastic Anemia6.3. Chronic Lymphocytic Leukemia6.4. Osteopetrosis
7. Global Cancer Stem Cells Market, By Mode Of Action, 2019-2032 (USD Million)
7.1 Targeted Cancerous Stem Cells
7.1.1 By Anti-CSC Therapeutics
7.1.1.1 Pathway Inhibitors7.1.1.2 Surface Marker Based7.1.1.3 Immuno-evasion and Targeting Tumour Microenvironment7.1.1.4 Nanoparticle-based Therapies
7.1.2 Products
7.1.2.1 Cell-Culturing7.1.2.2 Cell-Separation7.1.2.3 Cell-Analysis7.1.2.4 Molecular Analysis
7.2 Stem Cell Based Cancer Therapy
7.2.1 Autologous SC Transplant
7.2.2 Allogeneic SC Transplant
8. Global Cancer Stem Cells Market, By Transplantation, 2019-2032 (USD Million)
8.1. Allogeneic Stem Cell Therapy8.2. Autologous Stem Cell Therapy
9. Global Cancer Stem Cells Market, By Application, 2019-2032 (USD Million)
9.1. Blood Cancer9.2. Breast Cancer9.3. Cervical Cancer9.4. Colorectal Cancer9.5. Lung Cancer9.6. Prostate Cancer
10. Global Cancer Stem Cells Market, By End Use, 2019-2032 (USD Million)
10.1 Cell Banks and Tissue Banks10.2 Hospital and Surgical Laboratories
10.3 Pharmaceutical and Biomedical Companies
11. Global Cancer Stem Cells Market, By Region, 2019-2032 (USD Million)
11.1 North America
11.1.1. United States11.1.2. Canada11.1.3. Mexico
11.2 Europe
11.2.1. Germany11.2.2. United Kingdom11.2.3. France11.2.4. Italy11.2.5. Spain11.2.6. Rest of Europe
11.3 Asia-Pacific
11.3.1. China11.3.2. Japan11.3.3. India11.3.4. Australia11.3.5. South Korea11.3.6. Rest of Asia-Pacific
11.4 South America
11.4.1. Brazil11.4.2. Argentina11.4.3. Rest of South America
11.5 Middle East & Africa
11.5.1. Kingdom of Saudi Arabia11.5.2. United Arab Emirates11.5.3. Rest of Middle East & Africa
12. Company Profiles
12.1 AbbVie Inc.
12.1.1. Company details12.1.2. Financial outlook12.1.3. Product summary12.1.4. Recent developments
12.2 Advanced Cell Diagnostics Inc.
12.2.1. Company details12.2.2. Financial outlook12.2.3. Product summary12.2.4. Recent developments
12.3 Bionomics
12.3.1. Company details12.3.2. Financial outlook12.3.3. Product summary12.3.4. Recent developments
12.4 BioNTech
12.4.1. Company details12.4.2. Financial outlook12.4.3. Product summary12.4.4. Recent developments
12.5 BioTime Inc.
12.5.1. Company details12.5.2. Financial outlook12.5.3. Product summary12.5.4. Recent developments
12.6 Caladrius Biosciences Inc.
12.6.1. Company details12.6.2. Financial outlook12.6.3. Product summary12.6.4. Recent developments
12.7 Celgene Corp.
12.7.1. Company details12.7.2. Financial outlook12.7.3. Product summary12.7.4. Recent developments
12.8 ExCellThera
12.8.1. Company details12.8.2. Financial outlook12.8.3. Product summary12.8.4. Recent developments
12.9 Gamida Cell
12.9.1. Company details12.9.2. Financial outlook12.9.3. Product summary12.9.4. Recent developments
12.10 Irvine Scientific
12.10.1. Company details12.10.2. Financial outlook12.10.3. Product summary12.10.4. Recent developments
12.11 Lonza
12.11.1. Company details12.11.2. Financial outlook12.11.3. Product summary12.11.4. Recent developments
12.12 MacroGenics Inc.
12.12.1. Company details12.12.2. Financial outlook12.12.3. Product summary12.12.4. Recent developments
12.13 Menarini Group
12.13.1. Company details12.13.2. Financial outlook12.13.3. Product summary12.13.4. Recent developments
12.14 Merck KGaA
12.14.1. Company details12.14.2. Financial outlook12.14.3. Product summary12.14.4. Recent developments
12.15 Mereo BioPharma
12.15.1. Company details12.15.2. Financial outlook12.15.3. Product summary12.15.4. Recent developments
12.16 Miltenyi Biotec
12.16.1. Company details12.16.2. Financial outlook12.16.3. Product summary12.16.4. Recent developments
12.17 PromoCell GmbH
12.17.1. Company details12.17.2. Financial outlook12.17.3. Product summary12.17.4. Recent developments
12.18 Propanc Biopharma
12.18.1. Company details12.18.2. Financial outlook12.18.3. Product summary12.18.4. Recent developments
12.19 Silicon Biosystems
12.19.1. Company details12.19.2. Financial outlook12.19.3. Product summary12.19.4. Recent developments
12.20 Sino Biological Inc.
12.20.1. Company details12.20.2. Financial outlook12.20.3. Product summary12.20.4. Recent developments
12.21 Thermo Fisher Scientific Inc.
12.21.1. Company details12.21.2. Financial outlook12.21.3. Product summary12.21.4. Recent developments
12.22 VIaCyte Inc.
12.22.1. Company details12.22.2. Financial outlook12.22.3. Product summary12.22.4. Recent developments
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
The North America region is anticipated to have the highest market share in the Cancer Stem Cells Market.
The Cancer Stem Cells Market is projected to reach USD 2.68 billion by 2032, growing at a CAGR of 10.29% during the forecast period.
The Cancer Stem Cells Market grew in market size from 2021. The Market is expected to reach USD 2.68 billion by 2032, at a CAGR of 10.29% during the forecast period.
The Cancer Stem Cells Market CAGR of 10.29% during the forecast period.
You can get the sample pages by clicking the link - Click Here
The Cancer Stem Cells Market size is USD 2.68 billion from 2022 to 2032.
The Cancer Stem Cells Market segment is Covered By Cancer, By Mode Of Action, By Transplantation, By Application, By End User.
The key players in the market include Companies Covered AbbVie Inc., Advanced Cell Diagnostics Inc., Bionomics, BioNTech, BioTime Inc., Caladrius Biosciences Inc., Celgene Corp., ExCellThera, Gamida Cell, Irvine Scientific, Lonza, MacroGenics, Inc., Menarini Group, Merck KGaA, Mereo BioPharma, Miltenyi, Biotec, PromoCell GmbH, Propanc Biopharma, Silicon Biosystems, Sino Biological Inc., Thermo Fisher Scientific Inc., ViaCyte Inc.
The growing global cancer incidence is the key force driving the growth of the cancer stem cell market.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
